MMP1 drives tumor progression in large cell carcinoma of the lung through fibroblast senescence.


Journal

Cancer letters
ISSN: 1872-7980
Titre abrégé: Cancer Lett
Pays: Ireland
ID NLM: 7600053

Informations de publication

Date de publication:
01 06 2021
Historique:
received: 20 11 2020
revised: 09 01 2021
accepted: 28 01 2021
pubmed: 9 3 2021
medline: 21 10 2021
entrez: 8 3 2021
Statut: ppublish

Résumé

Large cell carcinoma (LCC) is a rare and aggressive lung cancer subtype with poor prognosis and no targeted therapies. Tumor-associated fibroblasts (TAFs) derived from LCC tumors exhibit premature senescence, and coculture of pulmonary fibroblasts with LCC cell lines selectively induces fibroblast senescence, which in turn drives LCC cell growth and invasion. Here we identify MMP1 as overexpressed specifically in LCC cell lines, and we show that expression of MMP1 by LCC cells is necessary for induction of fibroblast senescence and consequent tumor promotion in both cell culture and mouse models. We also show that MMP1, in combination with TGF-β1, is sufficient to induce fibroblast senescence and consequent LCC promotion. Furthermore, we implicate PAR-1 and oxidative stress in MMP1/TGF-β1-induced TAF senescence. Our results establish an entirely new role for MMP1 in cancer, and support a novel therapeutic strategy in LCC based on targeting senescent TAFs.

Identifiants

pubmed: 33684534
pii: S0304-3835(21)00052-5
doi: 10.1016/j.canlet.2021.01.028
pmc: PMC8026696
mid: NIHMS1683888
pii:
doi:

Substances chimiques

Receptor, PAR-1 0
TGFB1 protein, human 0
Transforming Growth Factor beta1 0
MMP1 protein, human EC 3.4.24.7
Matrix Metalloproteinase 1 EC 3.4.24.7

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1-12

Subventions

Organisme : NIGMS NIH HHS
ID : R01 GM132100
Pays : United States

Informations de copyright

Copyright © 2021 The Authors. Published by Elsevier B.V. All rights reserved.

Références

Clin Cancer Res. 2013 Jan 1;19(1):194-204
pubmed: 23032747
Sci Transl Med. 2012 Jul 11;4(142):142ra95
pubmed: 22786680
Hum Pathol. 2001 Mar;32(3):327-32
pubmed: 11274643
J Biol Chem. 2012 May 4;287(19):15935-46
pubmed: 22427646
J Cancer. 2018 Mar 14;9(7):1248-1258
pubmed: 29675106
Nat Commun. 2016 Jun 08;7:11762
pubmed: 27272654
J Cell Sci. 2007 Mar 15;120(Pt 6):921-8
pubmed: 17344429
Int J Cancer. 1999 Mar 1;80(5):756-63
pubmed: 10048979
Mol Cancer Res. 2015 Jan;13(1):161-73
pubmed: 25280968
Proc Natl Acad Sci U S A. 2006 Oct 31;103(44):16472-7
pubmed: 17060621
Lung Cancer. 2019 Sep;135:151-160
pubmed: 31446988
Integr Biol (Camb). 2012 Apr;4(4):440-8
pubmed: 22089949
Oncotarget. 2016 Dec 13;7(50):82324-82337
pubmed: 27384989
Carcinogenesis. 2013 Jun;34(6):1286-95
pubmed: 23358854
Semin Diagn Pathol. 2014 Jul;31(4):278-88
pubmed: 25023633
Sci Rep. 2019 Feb 12;9(1):1844
pubmed: 30755669
Cell. 2010 Apr 2;141(1):52-67
pubmed: 20371345
Hum Pathol. 2012 Mar;43(3):339-49
pubmed: 21840566
Br J Cancer. 2019 Oct;121(8):679-689
pubmed: 31481734
Cancer Res. 2020 Jan 15;80(2):276-290
pubmed: 31694906
CA Cancer J Clin. 2018 Jan;68(1):7-30
pubmed: 29313949
Br J Cancer. 2017 Oct 10;117(8):1128-1138
pubmed: 28898237
PLoS Biol. 2020 Jan 16;18(1):e3000599
pubmed: 31945054
Chest. 2007 Oct;132(4):1311-21
pubmed: 17934117
Exp Eye Res. 2016 Jan;142:56-70
pubmed: 26192991
Tumour Biol. 2015 Jun;36(6):4681-8
pubmed: 25638031
Aging Cell. 2017 Feb;16(1):192-197
pubmed: 28165661
Am J Pathol. 2009 Jan;174(1):101-14
pubmed: 19116368
Melanoma Res. 2007 Aug;17(4):205-13
pubmed: 17625450
Cell Cycle. 2012 Jun 15;11(12):2285-302
pubmed: 22684298
Carcinogenesis. 2017 Aug 1;38(8):766-780
pubmed: 28637319
J Biol Chem. 2012 Jun 29;287(27):22988-97
pubmed: 22573319
Nat Med. 2018 Aug;24(8):1277-1289
pubmed: 29988129
Ann Thorac Surg. 2014 Sep;98(3):1013-9
pubmed: 25085555
J Biol Chem. 2013 May 17;288(20):14647-14656
pubmed: 23548910
J Thorac Oncol. 2015 Sep;10(9):1243-1260
pubmed: 26291008
Mol Cell Biol. 1995 Oct;15(10):5732-9
pubmed: 7565725
Nat Rev Mol Cell Biol. 2014 Jul;15(7):482-96
pubmed: 24954210
Mol Cancer Res. 2017 Jan;15(1):3-14
pubmed: 27678171

Auteurs

Marta Gabasa (M)

Unit of Biophysics and Bioengineering, Department of Biomedicine, School of Medicine and Health Sciences, Universitat de Barcelona, Barcelona, 08036, Spain.

Evette S Radisky (ES)

Department of Cancer Biology, Mayo Clinic, Jacksonville, FL, 32224, USA.

Rafael Ikemori (R)

Unit of Biophysics and Bioengineering, Department of Biomedicine, School of Medicine and Health Sciences, Universitat de Barcelona, Barcelona, 08036, Spain.

Giulia Bertolini (G)

Tumor Genomics Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, 20133, Italy.

Marselina Arshakyan (M)

Unit of Biophysics and Bioengineering, Department of Biomedicine, School of Medicine and Health Sciences, Universitat de Barcelona, Barcelona, 08036, Spain.

Alexandra Hockla (A)

Department of Cancer Biology, Mayo Clinic, Jacksonville, FL, 32224, USA.

Paula Duch (P)

Unit of Biophysics and Bioengineering, Department of Biomedicine, School of Medicine and Health Sciences, Universitat de Barcelona, Barcelona, 08036, Spain.

Ornella Rondinone (O)

Tumor Genomics Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, 20133, Italy.

Alejandro Llorente (A)

Unit of Biophysics and Bioengineering, Department of Biomedicine, School of Medicine and Health Sciences, Universitat de Barcelona, Barcelona, 08036, Spain.

Maria Maqueda (M)

Department of ESAII, Center for Biomedical Engineering Research, Technical University of Catalonia (UPC), CIBER de Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), Barcelona, 08028, Spain.

Albert Davalos (A)

Buck Institute for Age Research, Novato, CA 94945, USA.

Elena Gavilán (E)

Cell Dynamics and Signaling Department, Andalusian Molecular Biology and Regenerative Medicine Centre (CABIMER), CSIC, Sevilla, 41092, Spain.

Alexandre Perera (A)

Department of ESAII, Center for Biomedical Engineering Research, Technical University of Catalonia (UPC), CIBER de Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), Barcelona, 08028, Spain.

Josep Ramírez (J)

Pathology Service, Hospital Clínic de Barcelona, Barcelona, 08036, Spain; Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, Madrid, 28029, Spain; Thoracic Oncology Unit, Hospital Clinic Barcelona, Barcelona, 08036, Spain.

Pere Gascón (P)

Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, 08036, Spain; Department of Medicine, University of Barcelona, Barcelona, Spain.

Noemí Reguart (N)

Thoracic Oncology Unit, Hospital Clinic Barcelona, Barcelona, 08036, Spain; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, 08036, Spain.

Luca Roz (L)

Tumor Genomics Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, 20133, Italy.

Derek C Radisky (DC)

Department of Cancer Biology, Mayo Clinic, Jacksonville, FL, 32224, USA. Electronic address: Radisky.Derek@mayo.edu.

Jordi Alcaraz (J)

Unit of Biophysics and Bioengineering, Department of Biomedicine, School of Medicine and Health Sciences, Universitat de Barcelona, Barcelona, 08036, Spain; Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, Madrid, 28029, Spain; Thoracic Oncology Unit, Hospital Clinic Barcelona, Barcelona, 08036, Spain; Institute for Bioengineering of Catalonia (IBEC), The Barcelona Institute for Science and Technology (BIST), Barcelona, 08028, Spain. Electronic address: jalcaraz@ub.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH